Cargando…
Hepatitis C Reinfection in People Who Inject Drugs in Resource-Limited Countries: A Systematic Review and Analysis
Hepatitis C (HCV) is a global pandemic. The World Health Organization has developed a strategic plan for HCV elimination that focuses on low- and middle-income countries (LMICs) and high-risk populations, including people who inject drugs (PWID). While direct-acting antiviral (DAA) therapies are hig...
Autores principales: | Muller, Abbe, Vlahov, David, Akiyama, Matthew J., Kurth, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400365/ https://www.ncbi.nlm.nih.gov/pubmed/32659974 http://dx.doi.org/10.3390/ijerph17144951 |
Ejemplares similares
-
High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study
por: Sacks-Davis, Rachel, et al.
Publicado: (2013) -
Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs
por: Yeung, Alan, et al.
Publicado: (2022) -
Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden
por: Lindqvist, K., et al.
Publicado: (2023) -
Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya
por: Stone, Jack, et al.
Publicado: (2022) -
Hepatitis C reinfection in former and active injecting drug users in Belgium
por: Busschots, Dana, et al.
Publicado: (2021)